PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
62.73
Similar ESG score to ADAP's 62.74. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
55.83
Environmental score 1.1-1.2x ADAP's 50.00. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
63.77
Social score 80-90% of ADAP's 78.41. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
68.58
Governance score 1.1-1.2x ADAP's 59.80. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.